Bank Of New York Mellon Corp Cel Sci Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.17 - $3.13 $59,306 - $85,542	27,330 New	27,330 $63.4 Million
Q4 2022 Feb 14, 2023	BUY	$1.99 - $3.52 $54,386 - $96,201	27,330 New	27,330 $64,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $5.23 $5,685 - $9,623	-1,840 Reduced 6.25%	27,609 $86,000
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $256,583 - $496,260	-99,451 Reduced 77.15%	29,449 $132,000
Q1 2022 May 11, 2022	BUY	$3.93 - $7.7 $6,476 - $12,689	1,648 Added 1.3%	128,900 $506,000
Q4 2021 Feb 11, 2022	BUY	$7.1 - $12.82 $5,097 - $9,204	718 Added 0.57%	127,252 $904,000
Q3 2021 Nov 12, 2021	BUY	$7.64 - $12.49 $68,706 - $112,322	8,993 Added 7.65%	126,534 $1.39 Million
Q2 2021 Aug 11, 2021	SELL	$8.68 - $27.49 $218,302 - $691,373	-25,150 Reduced 17.63%	117,541 $1.02 Million
Q1 2021 May 13, 2021	SELL	$12.0 - $27.64 $37,896 - $87,287	-3,158 Reduced 2.17%	142,691 $2.17 Million
Q4 2020 Feb 09, 2021	SELL	$11.05 - $16.62 $33,890 - $50,973	-3,067 Reduced 2.06%	145,849 $1.7 Million
Q3 2020 Nov 12, 2020	SELL	$11.69 - $14.54 $40,786 - $50,730	-3,489 Reduced 2.29%	148,916 $1.9 Million
Q2 2020 Aug 12, 2020	BUY	$9.75 - $17.6 $297,960 - $537,856	30,560 Added 25.08%	152,405 $2.27 Million
Q1 2020 May 06, 2020	BUY	$7.54 - $17.05 $187,625 - $424,272	24,884 Added 25.66%	121,845 $1.41 Million
Q4 2019 Feb 14, 2020	BUY	$6.71 - $9.55 $18,902 - $26,902	2,817 Added 2.99%	96,961 $887,000
Q3 2019 Nov 07, 2019	BUY	$6.0 - $9.6 $115,368 - $184,588	19,228 Added 25.67%	94,144 $841,000
Q2 2019 Aug 12, 2019	BUY	$3.77 - $8.67 $147,399 - $338,979	39,098 Added 109.16%	74,916 $628,000
Q1 2019 May 14, 2019	BUY	$2.58 - $3.54 $57,910 - $79,458	22,446 Added 167.86%	35,818 $127,000
Q4 2018 Feb 11, 2019	BUY	$2.65 - $4.26 $35,435 - $56,964	13,372 New	13,372 $38,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account